240 related articles for article (PubMed ID: 15623572)
1. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.
Migeotte I; Riboldi E; Franssen JD; Grégoire F; Loison C; Wittamer V; Detheux M; Robberecht P; Costagliola S; Vassart G; Sozzani S; Parmentier M; Communi D
J Exp Med; 2005 Jan; 201(1):83-93. PubMed ID: 15623572
[TBL] [Abstract][Full Text] [Related]
2. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
[TBL] [Abstract][Full Text] [Related]
3. Trp-Arg-Trp-Trp-Trp-Trp antagonizes formyl peptide receptor like 2-mediated signaling.
Shin EH; Lee HY; Kim SD; Jo SH; Kim MK; Park KS; Lee H; Bae YS
Biochem Biophys Res Commun; 2006 Mar; 341(4):1317-22. PubMed ID: 16476585
[TBL] [Abstract][Full Text] [Related]
4. F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor.
Gao JL; Guillabert A; Hu J; Le Y; Urizar E; Seligman E; Fang KJ; Yuan X; Imbault V; Communi D; Wang JM; Parmentier M; Murphy PM; Migeotte I
J Immunol; 2007 Feb; 178(3):1450-6. PubMed ID: 17237393
[TBL] [Abstract][Full Text] [Related]
5. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
Rabiet MJ; Huet E; Boulay F
Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
[TBL] [Abstract][Full Text] [Related]
6. Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.
Devosse T; Guillabert A; D'Haene N; Berton A; De Nadai P; Noel S; Brait M; Franssen JD; Sozzani S; Salmon I; Parmentier M
J Immunol; 2009 Apr; 182(8):4974-84. PubMed ID: 19342677
[TBL] [Abstract][Full Text] [Related]
7. Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3.
Devosse T; Dutoit R; Migeotte I; De Nadai P; Imbault V; Communi D; Salmon I; Parmentier M
J Immunol; 2011 Aug; 187(3):1475-85. PubMed ID: 21709160
[TBL] [Abstract][Full Text] [Related]
8. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation.
Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ
J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529
[TBL] [Abstract][Full Text] [Related]
9. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2.
Kang HK; Lee HY; Kim MK; Park KS; Park YM; Kwak JY; Bae YS
J Immunol; 2005 Jul; 175(2):685-92. PubMed ID: 16002663
[TBL] [Abstract][Full Text] [Related]
10. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
[TBL] [Abstract][Full Text] [Related]
11. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
12. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.
Migeotte I; Communi D; Parmentier M
Cytokine Growth Factor Rev; 2006 Dec; 17(6):501-19. PubMed ID: 17084101
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29.
Brandenburg LO; Seyferth S; Wruck CJ; Koch T; Rosenstiel P; Lucius R; Pufe T
Mol Membr Biol; 2009 Aug; 26(5):371-83. PubMed ID: 19707939
[TBL] [Abstract][Full Text] [Related]
14. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
de Paulis A; Montuori N; Prevete N; Fiorentino I; Rossi FW; Visconte V; Rossi G; Marone G; Ragno P
J Immunol; 2004 Nov; 173(9):5739-48. PubMed ID: 15494526
[TBL] [Abstract][Full Text] [Related]
15. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family.
Ernst S; Lange C; Wilbers A; Goebeler V; Gerke V; Rescher U
J Immunol; 2004 Jun; 172(12):7669-76. PubMed ID: 15187149
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of formyl peptide receptor signaling by peptide ligands.
Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
[TBL] [Abstract][Full Text] [Related]
17. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of formyl peptide receptor-like 1 by peptide ligands.
Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH
J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886
[TBL] [Abstract][Full Text] [Related]
19. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
[TBL] [Abstract][Full Text] [Related]
20. Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells.
Su LD; Peng JM; Ge YB
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):95-100. PubMed ID: 29364475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
